Gainers
- Tuesday Morning Corporation (NASDAQ:TUEM) rose 72.1% to $0.3420 in pre-market trading after dipping 30% on Wednesday. Tuesday Morning recently announced partnership with Intalytics for customized location intelligence solutions.
- Addex Therapeutics Ltd (NASDAQ:ADXN) rose 62.3% to $1.49 in pre-market trading after the company issued corporate update and financial guidance.
- Super Micro Computer, Inc. (NASDAQ:SMCI) rose 18.8% to $54.17 in pre-market trading after the company issued Q4 sales guidance above estimates.
- AIM ImmunoTech Inc. (NYSE:AIM) rose 16.2% to $0.9299 in pre-market trading after gaining 11% on Wednesday. AIM ImmunoTech reported follow-on data from its published single-center named patient program.
- Ur-Energy Inc. (NYSE:URG) rose 15.4% to $1.35 in pre-market trading after climbing around 4% on Wednesday.
- Scopus BioPharma Inc. (NASDAQ:SCPS) rose 14.4% to $0.45 in pre-market trading after gaining over 6% on Wednesday.
- Gorilla Technology Group Inc. (NASDAQ:GRRR) rose 13.9% to $15.00 in pre-market trading after declining more than 7% on Wednesday.
- Exela Technologies, Inc. (NASDAQ:XELA) rose 11.4% to $0.1687 in pre-market trading after jumping 14% on Wednesday.
- Endo International plc (NASDAQ:ENDP) rose 10.4% to $0.4575 in pre-market trading. Endo International is considering bankruptcy filing to restructure its more than $8 billion of debt and several outstanding lawsuits without a deal with opioid plaintiffs, the Wall Street Journal reported last week.
- Visionary Education Technology Holdings Group Inc. (NASDAQ:VEDU) rose 9.8% to $1.35 in pre-market trading.
- Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) rose 9.4% to $0.2993 in pre-market trading.
- Avenue Therapeutics, Inc. (NASDAQ:ATXI) rose 7.8% to $0.33 in pre-market trading.
- Nokia Oyj (NYSE:NOK) rose 6.6% to $5.01 in pre-market trading after reporting upbeat Q2 profit.
- Alcoa Corporation (NYSE:AA) rose 5.9% to $47.72 in pre-market trading as the company reported upbeat results for its second quarter on Wednesday.
- Tesla, Inc. (NASDAQ:TSLA) rose 2.3% to $759.80 in pre-market trading. Tesla posted better-than-expected earnings for its second quarter, while sales missed estimates. Second-quarter deliveries were 254,695, up 27% year-over-year.
